🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a pilot phase 1b study to investigate the safety and side effects o...
Status
Completed
Location
University of California, San Diego
Start Date
2018-08-15
Trial ID
NCT02776917
Treatments Being Tested
The purpose of this study is to test the safety of a combination of two ant...
Status
Completed
Location
Center for Lymphoid Malignancies at CUMC
Start Date
2008-06
Trial ID
NCT00691210
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Status
Recruiting
Location
Keck Medicine of USC Koreatown
Start Date
2023-08-10
Trial ID
NCT05372640
The advent of immunotherapy (immune checkpoint inhibitors \[ICI\]) has been...
Status
Active Not Recruiting
Location
Beatson West of Scotland Cancer Centre
Start Date
2022-08-30
Trial ID
NCT06597045
Treatments Being Tested
This is a phase II clinical study evaluating the safety, tolerability, phar...
Status
Recruiting
Location
SunYat-sen University Cancer Center
Start Date
2026-07-10
Trial ID
NCT07669779
Treatments Being Tested
The main goal of this study is to evaluate how safe and tolerable RNDO-564 ...
Status
Enrolling By Invitation
Location
UCSF Medical Center
Start Date
2025-11-17
Trial ID
NCT07218003
Treatments Being Tested
This study is a multi-regional, open-label phase I study to evaluate the Sa...
Status
Recruiting
Location
the second affiliated hospital of AMU
Start Date
2026-05-21
Trial ID
NCT07559019
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
Usc Norris Comprehensive Cancer Center (Nccc)
Start Date
2024-12-09
Trial ID
NCT06625593
Treatments Being Tested
This is an open-label, randomized, multi-site, Phase II, interventional tri...
Status
Completed
Location
University Of Arizona College Of Medicine
Start Date
2021-05-19
Trial ID
NCT04526899
Treatments Being Tested